Top Growth Stocks Revenue
SolarEdge Technologies: AI Data Centers as a new Multi-Billion Dollar Opportunity!
nLight: Strategic Shift Transforms Laser Specialist into a High-Flyer in the Defense Sector
After the withdrawal from low-margin industrial markets, nLight is focusing on the defense sector...
Ubiquiti: Record Figures and Short Squeeze Propel the Networking Equipment Manufacturer to an all-Time High!
Ubiquiti benefits long-term from the trend towards Wi-Fi 7 and cloud-based network management solutions...
Lumentum Holdings Announces Revenue Target of $2 Billion – Market Potential Explodes to $90 Billion!
Announcements at the OFC 2026 create momentum. The revenue share of cloud transceivers, optical circuit...
Micron Technology Starts HBM4 Mass Production for Vera Rubin
Micron reinforces its technological leadership with the launch of mass production of the new HBM4...
Ligand Pharmaceuticals: Dominance in the Biopharma Royalty Market – Licensing Revenues Expected to Increase by 23% Annually by 2030!
Ligand Pharmaceuticals stands out in the biopharmaceutical industry with a high-margin, low-risk...
ImmunityBio Bets on the Immune System – EU Approval Drives Biotech Stock
EU approval as a game changer: Anktiva gets the green light in Europe – the ImmunityBio stock skyrockets...
Nextpower: From Tracker Market Leader to Integrated Solar Platform
Substantive strategy shift: Nextpower (formerly Nextracker) expands its tracker dominance to an integrated...
Hecla Mining: From Conglomerate to Focused Silver Producer
From turnaround case to debt-free silver champion: Through the strategic sale of Casa Berardi and...
Super Bowl as a Price Catalyst: Hims & Hers Relies Again on Maximum Attention
Provocation at Prime Time: Hims & Hers is attacking the two-tier healthcare system at the Super...
Rambus Unleashed: Why the {[“Second Tier”]} of the AI Revolution is Now Taking Over
12% Gain thanks to "Memory Wall": Rambus reaches new highs as investors recognize the chip specialist...
Needham as a Catalyst: LightPath Becomes a Defense Story
The China break: How LightPath is breaking the Germanium monopoly from the East with its patented...
Array Technologies: Market Leader at a Discount Price – a bet on America's Energy Transition and the end of Grid Delays
The new driver: New management and analyst upgrades (TD Cowen: "Buy") create momentum. The valuation:...
Rocket Companies: The Fintech Giant in the Wake of Trump's Real Estate Offensive
From Intermediary to Fintech Giant: How Rocket Companies Dominates the US Real Estate Market through...
AeroVironment: Vertical Takeoff Thanks to Trump's $1.5 Trillion Announcement
$1.5 trillion flight of fancy: Trump's budget proposal for 2027 triggers a massive sector rotation...
Saab: Sweden's Fighter Jets Focus Around Venezuela
The Venezuela escalation has boosted the European defense sector at the beginning of 2026 Saab has...
LightPath Technologies: From Component Supplier to System Partner for the Future of Defense
Explosive Growth Through System Integration: With a revenue increase of 79% in the most recent quarter...
ACM Research Benefits from China's Chip Offensive and Expands Internationally
Growth Despite Headwinds: ACM Research reports a Q3 2025 revenue of $269 million (+32%) and becomes...
First Solar: Solar Exception with AI Tailwind
Technological Independence: Thanks to CdTe thin-film technology, First Solar avoids the global pricing...
Lemonade: The AI Insurance bet is now Finally Backed up by Reliable Figures
Lemonade makes the narrative tangible: growth plus significantly better loss ratio. Short squeeze...
Innodata (INOD): -30% since November – Is the AI Highflyer now a Buy?
Fundamental contrast: Despite a 23% drop in November, $68 million in new pre-training contracts and...
Alignment Health: From Growth Promise to Profitability Story
Growth in the senior market: Medicare Advantage as a huge, government-framed market – Alignment...
Nutex Health: Micro Hospitals, Macro Opportunity – Regulation as a Fate Factor
Nutex combines micro hospitals with the IDR arbitration process as a revenue lever – this has massively...
Rhythm Pharmaceuticals: PWS Early Data Fuels Optimism for the Stock – aHO Decision on March 20, 2026, Remains the Main Driver
Commercially already on the market: IMCIVREE (Setmelanotid) reduces the "all-or-nothing" risk of...